Press Contact
For media enquiries, please reach out to: contact@aspivix.com

All
  • All
  • Blog
  • In the media
  • Press releases

Welcoming Excellence to Aspivix’s Board: Dr. Susan Nicholson and Jessica J. Federer

Epalinges, Switzerland – December 11, 2023 – Dr. Susan Nicholson & Jessica J. Federer join Aspivix's Board of Directors alongside Keren Leshem, fortifying the Company’s Leadership in Women's Health Care Innovation. At...
Read More about Welcoming Excellence to Aspivix’s Board: Dr. Susan Nicholson and Jessica J. Federer

Aspivix CEO Mathieu Horras Discusses How Much IUD Insertion Can Hurt Less on X-Health.show

Renens, Switzerland - 3 October 2023 - Mathieu Horras, CEO of Aspivix, recently joined Alex Jani on the X-Health.show podcast to delve into pressing issues and innovations in women's healthcare concerning IUD...
Read More about Aspivix CEO Mathieu Horras Discusses How Much IUD Insertion Can Hurt Less on X-Health.show

Aspivix Featured in Forbes France Following Top 10 Placement at Inaugural MedFemTech Congress

Renens, Switzerland – 10 May 2023 – ASPIVIX SA, a leading Swiss startup in women's healthcare, is thrilled to announce its feature in Forbes France after securing a spot in the top...
Read More about Aspivix Featured in Forbes France Following Top 10 Placement at Inaugural MedFemTech Congress

Aspivix receives U.S. FDA 510(k) Clearance for Carevix™, Their Novel Cervical Stabilizer

Renens, Switzerland – 26 January 2023 – ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological care, today announced that Carevix™, its novel Atraumatic Cervical Stabilizer, has received 510(k)...
Read More about Aspivix receives U.S. FDA 510(k) Clearance for Carevix™, Their Novel Cervical Stabilizer